Vasalgel, a non-hormonal form of male contraceptive, which is currently being developed, may change the contraception game for good.
It would be the first approved male contraceptive since the condom and was being developed by The Parsemus Foundation, a non-profit whose website stated it "works to advance innovative and neglected medical research," News.com.au has reported.
Vasalgel is essentially a gel that is injected (under local anaesthetic) into a man's sperm-carrying tubes called vas deferens, accessible through the scrotum.
It works by blocking sperm and is expected to be reversible through a second injection that dissolves the "gel", which is a kind of polymer. One injection of the drug is expected to last up to ten years.
If all goes according to plan, the contraception could be available for consumers as early as 2018.
